NEW YORK, Feb. 13, 2023 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against certain…
NEW YORK, Feb. 13, 2023 /PRNewswire/ -- Attention Fate Therapeutics, Inc. ("Fate") (NASDAQ: FATE) shareholders: The Law Offices of Vincent…
San Diego, California--(Newsfile Corp. - February 10, 2023) - The law firm of Robbins Geller Rudman & Dowd LLP announces…
New York, New York--(Newsfile Corp. - February 10, 2023) - Pomerantz LLP announces that a class action lawsuit has been…
NEW YORK, Feb. 10, 2023 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on…
New York, New York--(Newsfile Corp. - February 9, 2023) - Levi & Korsinsky, LLP notifies investors in Fate Therapeutics, Inc.…
NEW YORK, Feb. 9, 2023 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Fate Therapeutics, Inc. ("Fate" or the…
New York, New York--(Newsfile Corp. - February 8, 2023) - The securities litigation law firm of The Gross Law Firm…
NEW YORK, Feb. 8, 2023 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Fate Therapeutics,…
NEW YORK, Feb. 7, 2023 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed…
NEW YORK, Feb. 7, 2023 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against certain…
BENSALEM, Pa., Feb. 6, 2023 /PRNewswire/ -- Law Offices of Howard G. Smith announces that investors with substantial losses have…
NEW YORK, Feb. 5, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of…
New York, New York--(Newsfile Corp. - February 3, 2023) - WHY: Rosen Law Firm, a global investor rights law firm, reminds…
New York, New York--(Newsfile Corp. - February 2, 2023) - Pomerantz LLP announces that a class action lawsuit has been…
NEW YORK, Feb. 2, 2023 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Fate Therapeutics, Inc. ("Fate" or the…
NEW YORK, Feb. 1, 2023 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class…
Los Angeles, California--(Newsfile Corp. - January 31, 2023) - The Schall Law Firm, a national shareholder rights litigation firm, reminds…
NEW YORK, Jan. 31, 2023 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed…
NEW YORK, Jan. 30, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of…
Los Angeles, California--(Newsfile Corp. - January 30, 2023) - The Schall Law Firm, a national shareholder rights litigation firm, reminds…
NEW YORK, Jan. 30, 2023 /PRNewswire/ -- Attention Fate Therapeutics, Inc. ("Fate") (NASDAQ: FATE) shareholders: The Law Offices of Vincent…
SAN DIEGO, Jan. 28, 2023 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Fate…
NEW YORK, Jan. 27, 2023 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against certain…
New York, New York--(Newsfile Corp. - January 27, 2023) - WHY: Rosen Law Firm, a global investor rights law firm, announces…
Los Angeles, California--(Newsfile Corp. - January 26, 2023) - The Schall Law Firm, a national shareholder rights litigation firm, reminds…
NEW YORK, Jan. 26, 2023 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Fate Therapeutics, Inc. ("Fate" or the…
New York, New York--(Newsfile Corp. - January 25, 2023) - Pomerantz LLP announces that a class action lawsuit has been…
Los Angeles, California--(Newsfile Corp. - January 25, 2023) - The Schall Law Firm, a national shareholder rights litigation firm, reminds…
San Diego, California--(Newsfile Corp. - January 24, 2023) - Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers…
NEW YORK, Jan. 24, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing…
New York, New York--(Newsfile Corp. - January 24, 2023) - Levi & Korsinsky, LLP notifies investors in Fate Therapeutics, Inc.…
Los Angeles, California--(Newsfile Corp. - January 24, 2023) - The Schall Law Firm, a national shareholder rights litigation firm, reminds…
Los Angeles, California--(Newsfile Corp. - January 23, 2023) - The Schall Law Firm, a national shareholder rights litigation firm, reminds…
Boston, Massachusetts--(Newsfile Corp. - January 23, 2023) - Block & Leviton announces that a class action lawsuit has been filed…
FATE Class Action Investigation has Commenced on Behalf of ShareholdersSan Diego, California--(Newsfile Corp. - January 21, 2023) - Shareholder rights…
Los Angeles, California--(Newsfile Corp. - January 19, 2023) - The Schall Law Firm, a national shareholder rights litigation firm, announces…
Boston, Massachusetts--(Newsfile Corp. - January 17, 2023) - Block & Leviton is investigating Fate Therapeutics, Inc. (NASDAQ: FATE) for…
Mendlein, John - Aufsichtsrat - Tag der Transaktion: 2023-01-13...…
Mendlein, John - Aufsichtsrat - Tag der Transaktion: 2023-01-11...…
Los Angeles, California--(Newsfile Corp. - January 12, 2023) - The Schall Law Firm, a national shareholder rights litigation firm, announces…
Plavsic, Mark - Vorstand - Tag der Transaktion: 2023-01-10...…
Chu, Yu-Waye - Vorstand - Tag der Transaktion: 2023-01-10...…
Boston, Massachusetts--(Newsfile Corp. - January 11, 2023) - Block & Leviton is investigating Fate Therapeutics, Inc. (NASDAQ: FATE) for…
Los Angeles, California--(Newsfile Corp. - January 11, 2023) - The Schall Law Firm, a national shareholder rights litigation firm, announces…
Los Angeles, California--(Newsfile Corp. - January 10, 2023) - The Schall Law Firm, a national shareholder rights litigation firm, announces…
Fate Therapeutics's (NASDAQ:FATE) short percent of float has fallen 4.62% since its last report. The company recently reported that it…
Boston, Massachusetts--(Newsfile Corp. - January 6, 2023) - Block & Leviton is investigating Fate Therapeutics, Inc. (NASDAQ: FATE) for potential…
Shares of Fate Therapeutics Inc. FATE plunged 56.8% in premarket trading, putting them on track for a record one-day selloff,…
Stocks to Watch: World Wrestling Ent., Spruce Bios, CytomX Therapeutics, Graphite Bio, Fate Therapeutics...…